The requirement of SREBP activation for the development of hepatic steatosis and hypertriglyceridemia was demonstrated by studies in which SCAP, a protein required for SREBP activation, was deleted in obese, insulin resistant mice (ob/ob mice) that normally have very high levels of hepatic FA and TG synthesis. The gene discussed is INS; the disease is fatty liver disease.